DY268
DY268 is a potent and selective FXR antagonist with an IC50 of 7.5 nM, derived from a trisubstituted pyrazolamide scaffold. It exhibits no FXR agonist activity or cytotoxicity, making it a valuable research tool for investigating FXR-related pathways in metabolic and liver diseases during in vitro and in vivo studies.
Product Specifications
CAS Number
1609564-75-1
Product Name Alternative
DY 268, DY268, DY-268, FXR, Inhibitor, inhibit, NR1H4
Field of Research
Metabolism Research
Purity
98.48% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (8.92 mM) ; DMSO:50 mg/mL (89.18 mM) ; H2O:Insoluble
Smiles
C (NC1=CC (S (=O) (=O) N2CCOCC2) =C (C) C=C1) (=O) C=3C (=NN (CC4=CC (OC) =CC=C4) C3) C5=CC=C (C) C=C5
Molecular Formula
C30H32N4O5S
Molecular Weight
560.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV624449 1.0 µg DNA
PMEPA1 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 